Cannabinoid may treat brain cancer
Tuesday, September 25, 2012 - 16:00
in Health & Medicine
Researchers are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol. Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.